Ngā hua rapu - Carmelo Scarpignato

Whakamahine hua
  1. 1
    Piroxicam-β-Cyclodextrin: A GI Safer Piroxicam

    Piroxicam-β-Cyclodextrin: A GI Safer Piroxicam mā Carmelo Scarpignato

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Systematic review with meta‐analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth

    Systematic review with meta‐analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth mā Luigi Gatta, Carmelo Scarpignato

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease?

    Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease? mā Richard H. Hunt, Carmelo Scarpignato

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Editorial
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments

    Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments mā Carmelo Scarpignato, Richard H. Hunt

    I whakaputaina 2024
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non‐erosive reflux disease – efficacy of Esoxx, a hyaluronic acid–chondroitin sulphate based bioadhesive formulation

    Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non‐erosive reflux disease – efficacy of Esoxx, a hyaluronic acid–chondroitin sulph... mā Vincenzo Savarino, Fábio Pace, Carmelo Scarpignato

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Ageusia, gastrointestinal symptoms and marked asthenia in late December. A single case report with positive SARS-Cov2 IgG in Italy

    Ageusia, gastrointestinal symptoms and marked asthenia in late December. A single case report with positive SARS-Cov2 IgG in Italy mā Paolo, Caffarra, Carmelo, Scarpignato, Marcello, Maggio

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Impact of crystal polymorphism on the systemic bioavailability of rifaximin, an antibiotic acting locally in the gastrointestinal tract, in healthy volunteers

    Impact of crystal polymorphism on the systemic bioavailability of rifaximin, an antibiotic acting locally in the gastrointestinal tract, in healthy volunteers mā Carmelo Scarpignato, Corrado Blandizzi, G.C. Viscomi

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Oesophageal corrosive injuries in children: a forgotten social and health challenge in developing countries

    Oesophageal corrosive injuries in children: a forgotten social and health challenge in developing countries mā Sandro Contini, Alim Swarray‐Deen, Carmelo Scarpignato

    I whakaputaina 2009
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Review article: do stimulant laxatives damage the gut? A critical analysis of current knowledge

    Review article: do stimulant laxatives damage the gut? A critical analysis of current knowledge mā Peter J. Whorwell, Robert Lange, Carmelo Scarpignato

    I whakaputaina 2024
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy

    Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy mā Luigi Gatta, Nimish Vakil, D. Vaira, Carmelo Scarpignato

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Effective and safe proton pump inhibitor therapy in acid-related diseases – A position paper addressing benefits and potential harms of acid suppression

    Effective and safe proton pump inhibitor therapy in acid-related diseases – A position paper addressing benefits and potential harms of acid suppression mā Carmelo Scarpignato, Luigi Gatta, Angelo Zullo, Corrado Blandizzi

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Revisiting Montreal: New Insights into Symptoms and Their Causes, and Implications for the Future of GERD

    Revisiting Montreal: New Insights into Symptoms and Their Causes, and Implications for the Future of GERD mā A. P. S. Hungin, Michael Molloy‐Bland, Carmelo Scarpignato

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Determinants of the short‐term gastric damage caused by NSAIDs in man

    Determinants of the short‐term gastric damage caused by NSAIDs in man mā Ingvar Bjarnason, Carmelo Scarpignato, Koji Takeuchi, K. D. Rainsford

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Management of colonic diverticular disease in the third millennium: Highlights from a symposium held during the United European Gastroenterology Week 2017

    Management of colonic diverticular disease in the third millennium: Highlights from a symposium held during the United European Gastroenterology Week 2017 mā Carmelo Scarpignato, Giovanni Barbara, Ángel Lanas, Lisa L. Strate

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis – an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks

    Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis – an expert consensus addressing benefits as well as gastrointestinal and cardiovascular r... mā Carmelo Scarpignato, Ángel Lanas, Corrado Blandizzi, Willem F. Lems, Matthias Hermann, Richard H. Hunt

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs

    Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs mā Ingvar Bjarnason, Carmelo Scarpignato, Erik Holmgren, Michael W. Olszewski, K. D. Rainsford, Ángel Lanas

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Reflux related symptoms in patients with normal oesophageal exposure to acid.

    Reflux related symptoms in patients with normal oesophageal exposure to acid. mā G.Y. Shi, Stanislas Bruley des Varannes, Carmelo Scarpignato, Marc Le Rhun, J. P. Galmiche

    I whakaputaina 1995
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Impact of primary antibiotic resistance on the effectiveness of sequential therapy for <i>Helicobacter pylori</i> infection: lessons from a 5-year study on a large number of strains

    Impact of primary antibiotic resistance on the effectiveness of sequential therapy for <i>Helicobacter pylori</i> infection: lessons from a 5-year study on a large number of strain... mā Luigi Gatta, Carmelo Scarpignato, Giulia Fiorini, Jonathan Belsey, Ilaria Maria Saracino, Carlo Ricci, D. Vaira

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Colonic diverticular disease

    Colonic diverticular disease mā Antonio Tursi, Carmelo Scarpignato, Lisa L. Strate, Ángel Lanas, Wolfgang Kruis, Adi Lahat, Silvio Danese

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Rifaximin Reduces the Number and Severity of Intestinal Lesions Associated With Use of Nonsteroidal Anti-Inflammatory Drugs in Humans

    Rifaximin Reduces the Number and Severity of Intestinal Lesions Associated With Use of Nonsteroidal Anti-Inflammatory Drugs in Humans mā Carmelo Scarpignato, Werner Dolak, Ángel Lanas, Peter Matzneller, Cecilia Renzulli, Maria Grimaldi, Markus Zeitlinger, Ingvar Bjarnason

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: